title: Polymorphism of vitamin D3 receptor and its relation to mineral bone density in perimenopausal women.
abstract: Postmenopausal osteoporosis is the most common metabolic bone disease with important genetic factors. We evaluated the frequency of polymorphism 283G/A of the vitamin D3 VDR gene receptor. The study included 800 women at the postmenopausal (505) and reproductive (295) age. Statistically significant changes, depending on the genotype, were shown.
  
  
  BACKGROUND
  Postmenopausal osteoporosis is the most common metabolic bone disease of strong genetic origin with population variability determined by the interaction of genetic and environmental factors. Recognition of different genetic variants underlying development of osteoporosis would make it possible to administer individual symptomatic treatment as well as early prophylactics of osteoporosis.
  
  
  METHODS
  The aim of the study was to evaluate the frequency of polymorphism 283G/A of the vitamin D3 VDR gene receptor and assessment of its relations with the clinical parameters of osseous turnover and degree of postmenopausal osteoporosis. The study included 800 women at the postmenopausal (505) and reproductive (295) age throughout the Wielkopolska region in Poland. The postmenopausal group included women with osteoporosis and osteopenia and the healthy ones. Women at the reproductive age were healthy. Frequency of the tested gene polymorphism was evaluated in the group where bone mineral density (BMD) was marked and in the control group.
  
  
  RESULTS
  The obtained test results pointed to correlation of polymorphism VDR 283G/A with the BMD scores for the lumbar vertebrae in women with osteopenia and osteoporosis, therefore the ones at risk of fractures. Vitamin D receptor (VDR) polymorphism correlated with reduced BMD values.
  
  
  CONCLUSIONS
  Polymorphism 283G/A of the vitamin D3 receptor gene has been proved to be the genetic factor of postmenopausal osteoporosis. The polymorphism mentioned above has been proved to be a factor of mineral bone density changes of women.
authors.affiliation: Department of Histology and Embryology, Medical University of Silesia, Jordana 19 Street, 41-808, Zabrze, Poland, metabolizm.db@gmail.com.
authors.forename: D
authors.initials: D
authors.lastname: Boroń
authors.forename: A
authors.initials: A
authors.lastname: Kamiński
authors.forename: D
authors.initials: D
authors.lastname: Kotrych
authors.forename: A
authors.initials: A
authors.lastname: Bogacz
authors.forename: I
authors.initials: I
authors.lastname: Uzar
authors.forename: P M
authors.initials: PM
authors.lastname: Mrozikiewicz
authors.forename: B
authors.initials: B
authors.lastname: Czerny
mesh_terms: D000328:Adult; D015519:Bone Density / Q000235:genetics*; D001851:Bone Diseases, Metabolic / Q000235:genetics / Q000503:physiopathology; D005260:Female; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D008159:Lumbar Vertebrae / Q000503:physiopathology; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000235:genetics* / Q000503:physiopathology; D047648:Perimenopause / Q000235:genetics / Q000502:physiology; D011110:Polymorphism, Genetic; D018167:Receptors, Calcitriol / Q000235:genetics*; D055815:Young Adult
chemical_list: D018167:Receptors, Calcitriol